Understanding Iatrogenic Cushing Syndrome: Unveiling the Hidden Dangers of Glucocorticoid Medications

Common Symptoms and Signs of Iatrogenic Cushing Syndrome to Watch For

The symptoms of iatrogenic Cushing syndrome can be striking and may include:

Weight Gain: A hallmark of Cushing syndrome, patients often experience rapid weight gain, particularly in the upper body and face, leading to a characteristic “moon face.”
Thin Arms and Legs: Muscle wasting can occur, resulting in thin limbs that contrast with a rounded torso.
Increased Fat Deposits: Accumulation of fat around the neck or upper back, sometimes referred to as a “buffalo hump.”
Thinning Skin: Skin becomes fragile, leading to easy bruising and slow healing of cuts and scratches.
Purple Stretch Marks: Striae may appear on the abdomen, breasts, hips, and underarms.
Ocular Hypertension: Increased pressure in the eyes, which may elevate the risk of glaucoma.
Metabolic Disorders: Issues such as hypertension, diabetes, dyslipidemia, and obesity are common in patients with Cushing syndrome.

Compared to endogenous Cushing syndrome, the symptoms of iatrogenic Cushing syndrome can be more pronounced due to the direct impact of glucocorticoids on bodily functions (Healthline, n.d.).

The Causes of Iatrogenic Cushing Syndrome: How Glucocorticoid Medications Trigger This Condition

Iatrogenic Cushing syndrome arises primarily from the use of glucocorticoids, which are powerful anti-inflammatory medications. These drugs are frequently prescribed for chronic conditions such as:

Rheumatoid Arthritis
Asthma
Systemic Lupus Erythematosus
Inflammatory Bowel disease

In some cases, herbal supplements such as Artri King, which have been found to contain undisclosed glucocorticoids, can also induce this condition (Healthline, n.d.). The risk of developing iatrogenic Cushing syndrome is particularly high when glucocorticoids are taken in high doses or over an extended period.

The mechanism behind this syndrome involves the suppression of the hypothalamic-pituitary-adrenal (HPA) axis, which leads to decreased production of endogenous cortisol by the adrenal glands. This suppression can result in a range of physiological changes, including:

Increased Appetite: Glucocorticoids can stimulate appetite, contributing to weight gain.
Altered Fat Distribution: The hormonal changes induced by glucocorticoids lead to changes in fat storage patterns.
Hypertension and Diabetes: Glucocorticoids interfere with glucose metabolism and can cause insulin resistance, leading to increased blood sugar levels and hypertension.

Diagnosis of Iatrogenic Cushing Syndrome: Tests and Evaluations for Accurate Detection

Diagnosing iatrogenic Cushing syndrome involves a combination of clinical evaluation and laboratory tests. A healthcare provider will typically begin with:

Medical History Review: Understanding the patient’s medication history, particularly regarding glucocorticoid use.
Physical Examination: Assessing physical signs such as weight gain, skin changes, and fat distribution.
Laboratory Tests: Common tests include:
- Twenty-four Hour Urinary Free-Cortisol Test: Measures cortisol levels in urine over 24 hours.
- Late Night Salivary Cortisol Test: Evaluates cortisol production at night when levels should be low.
- Low-Dose Dexamethasone Suppression Test: Assesses how cortisol levels respond to dexamethasone administration.

These tests help determine whether cortisol levels are elevated and whether the source of the excess cortisol is endogenous or exogenous (Healthline, n.d.).

Effective Treatment Strategies for Managing Iatrogenic Cushing Syndrome and Its Complications

The primary treatment for iatrogenic Cushing syndrome is to taper glucocorticoid use under the guidance of a healthcare provider. This process requires careful monitoring to avoid glucocorticoid withdrawal symptoms, which can include severe fatigue, joint pain, and body aches.

Key Treatment Strategies Include:

Gradual Dose Reduction: Slowly decreasing the dosage of glucocorticoids to allow the adrenal glands to recover their normal function.
Monitoring for Symptoms: Regular follow-up appointments to monitor symptoms and cortisol levels.
Lifestyle Modifications: Encouraging patients to adopt healthy eating and exercise habits to manage weight and mitigate other metabolic effects.

Without proper management, iatrogenic Cushing syndrome can lead to severe complications, including cardiovascular disease, osteoporosis, and severe infections (Healthline, n.d.).

FAQ Section

What is iatrogenic Cushing syndrome?

Iatrogenic Cushing syndrome is a condition caused by the prolonged use of glucocorticoid medications, leading to symptoms associated with excessive cortisol levels in the body.

How does glucocorticoid medication cause Cushing syndrome?

Glucocorticoids mimic cortisol and can suppress the body’s natural production of cortisol, leading to weight gain, thinning skin, and other symptoms of Cushing syndrome.

What are the long-term effects of untreated iatrogenic Cushing syndrome?

Long-term effects can include obesity, cardiovascular disease, diabetes, osteoporosis, and increased susceptibility to infections.

How can iatrogenic Cushing syndrome be prevented?

Prevention involves taking glucocorticoids as prescribed, avoiding exceeding recommended doses, and consulting healthcare providers about any side effects experienced.

References

Healthline. (n.d.). Iatrogenic Cushing syndrome: Symptoms, Causes, Treatment. Retrieved from https://www.healthline.com/health/endocrine-health/iatrogenic-cushing-syndrome
Toledano, Y., et al. (2024). Could low prolactin levels after radiotherapy predict the onset of hypopituitarism? Retrieved from https://doi.org/10.1007/s11154-024-09900-1
Krysiak, R., et al. (2024). (Un)Tying the Knot: Oxidative Stress, Inflammatory Markers, and Lipid Status in Dogs with Hypercortisolism. Retrieved from https://doi.org/10.3390/ani14233476
Bertanha, L., et al. (2024). Differential diagnosis of pigmented nail lesions. Retrieved from https://doi.org/10.1016/j.abd.2024.01.005
Ovarian Hyperstimulation and Maternal Virilisation with Successful Pregnancy Outcome: A case report. (2023). Retrieved from https://doi.org/10.18295/squmj.10.2023.064